← Back to Search

Kidney transplant biopsies for cause for Kidney Transplant Rejection

N/A
Recruiting
Led By Philip F Halloran, MD, PhD
Research Sponsored by University of Alberta
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
* All kidney transplant recipients undergoing a kidney biopsy for clinical indications, as determined by their physician or surgeon, will be eligible to enroll in the study.
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 18 months
Awards & highlights

Summary

Demonstrate the relationship between DD-cfDNA levels and HLA antibodies in blood, and the Molecular Microscope® (MMDx) Diagnostic System results in indication biopsies.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~18 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 18 months for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Calibration of Prospera test for T cell-mediated rejection
Calibration of Prospera test for antibody-mediated rejection
Calibration of Prospera test for kidney injury
+2 more
Secondary study objectives
Assessment of donor-specific antibody status
Determine if Prospera blood test can replace kidney biopsy test

Trial Design

1Treatment groups
Experimental Treatment
Group I: Kidney transplant biopsies for causeExperimental Treatment3 Interventions
The study population includes patients with a functioning kidney transplant undergoing a biopsy for clinical indications as standard of care.

Find a Location

Who is running the clinical trial?

Natera, Inc.Industry Sponsor
51 Previous Clinical Trials
41,397 Total Patients Enrolled
One LambdaUNKNOWN
2 Previous Clinical Trials
900 Total Patients Enrolled
University of AlbertaLead Sponsor
913 Previous Clinical Trials
390,133 Total Patients Enrolled
~58 spots leftby Dec 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top